nm23-H1 Antibodies

Santa Cruz Biotechnology provides a broad selection of nm23-H1 monoclonal antibodies for research focused on understanding cellular processes and disease mechanisms. nm23-H1 Antibodies targeting nm23-H1 are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). nm23-H1 has been identified as a key player in tumor metastasis suppression and cellular differentiation, making it particularly relevant in cancer research. The role of nm23-H1 extends to regulating essential cellular processes such as proliferation and apoptosis, which are crucial in both normal and pathological conditions. Research has shown that nm23-H1 expression levels often correlate with cancer progression and patient outcomes. Understanding nm23-H1 function and regulation can reveal new insights into cancer development and potential therapeutic strategies. Investigating nm23-H1 activity patterns across different tissue types helps illuminate its diverse biological functions. Santa Cruz Biotechnology monoclonal antibodies targeting nm23-H1 enable researchers worldwide to advance scientific understanding of cancer biology and cellular regulation.